col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

77 Results       Page 1

Mary Ann Liebert: Clinical OMICs
  original article Date Title Authors   All Authors
1 [GO] 2021―Dec―29 Can Our Success with HIV Serve as a Guide for Antiviral Drug Development for Covid-19?
2 [GO] 2021―Oct―13 Studies Differ on Efficacy of COVID-19 Convalescent Plasma Treatments
3 [GO] 2021―Oct―13 GWAS Reveals Multiple Host Genes Linked to Severe COVID-19 Symptoms
4 [GO] 2021―Oct―13 T Cells from Previous Coronavirus Infections Lead to Milder COVID-19 Symptoms
5 [GO] 2021―Oct―13 Airway Immune Cell Differences with Age May Explain Milder COVID-19 Symptoms in Children
6 [GO] 2021―Oct―13 SARS-CoV-2 Shows Tremendous Capacity to Adapt and Change
7 [GO] 2021―Oct―13 One-Hour Saliva-Based SARS-CoV-2 Test Developed
8 [GO] 2021―Aug―26 Antibody-Producing Cells Last At least One Year After COVID-19 Infection
9 [GO] 2021―Aug―26 Disappointing Late-Stage Results for CureVac's COVID-19 mRNA Vaccine Trial
10 [GO] 2021―Aug―26 Portable Saliva-Based COVID-19 Test is Quick, Accurate and Sensitive
11 [GO] 2021―Aug―26 NIH Begins COVID-19 Vaccine Booster Shot Trials
12 [GO] 2021―Aug―26 SARS-CoV-2 Reproductive Method Could Be Good Target for Therapies
13 [GO] 2021―Jun―18 Impact of Epigenetics on COVID-19
14 [GO] 2021―Jun―18 Leprosy Drug Shows Potential as At-Home Treatment for COVID-19
15 [GO] 2021―Jun―18 Common IBD Treatment Reduces Immune Response to COVID-19
16 [GO] 2021―Jun―18 Epigenetic Factors Predicting More Severe COVID-19 Revealed
17 [GO] 2021―Jun―18 Sussing Out COVID-19 Severity: Can genetic variability explain why some people become seriously ill with COVID-19 while others have only mild illness? Helen Albert
18 [GO] 2021―Jun―18 J&J COVID-19 Vaccine Pause Ended After Blood Clot Scare
19 [GO] 2021―Jun―18 Study Will Assess Reasons for Allergic Reactions to Moderna, Pfizer/BioNTech COVID-19 Vaccines
20 [GO] 2021―Jun―18 U.S. Slow to Sequence, Track SARS-CoV-2 Variants
21 [GO] 2021―Apr―09 Lilly COVID-19 Antibody Combination Gets Emergency Use Authorization from FDA
22 [GO] 2021―Apr―09 Long-Term Effects of COVID-19 Infection Detailed in New Study
23 [GO] 2021―Apr―09 The Race for a Smart Phone-Based COVID-19 Test Heats Up Malorye Allison Branca
24 [GO] 2021―Apr―09 Precisely, With William Haseltine, Ph.D.: Seasonal Population Immunity Is a Better Description for COVID-19 than “Herd” Immunity
25 [GO] 2021―Apr―09 Novavax and Janssen Report Positive Phase III Results for COVID-19 Vaccine Candidates
26 [GO] 2021―Apr―09 Some COVID-19 Vaccines More Effective Against New Strains Than Others
27 [GO] 2021―Apr―09 CRISPR-Based Tests Allows Fast, Accurate SARS-CoV-2 Identification
28 [GO] 2021―Feb―12 Llama Nanobody Shows Promise as Treatment for COVID-19
29 [GO] 2021―Feb―12 Sniffing out COVID-19
30 [GO] 2021―Feb―12 Patient Care During COVID-19: Lessons from monitoring transplant patients in the age of COVID-19 and deployment of molecular diagnostics in vulnerable populations Peter Maag
31 [GO] 2021―Feb―12 New Study Suggests COVID-19 Lung Damage Reduced in Patients Prescribed Fenofibrate
32 [GO] 2021―Feb―12 Gingko Bioworks Pilots Pooled COVID-19 Testing for Schools
33 [GO] 2021―Feb―12 Critical COVID-19 Testing Issues
34 [GO] 2021―Feb―12 Rapid SARS-CoV-2 testing: LAMP and antigen COVID-19 tests promise inexpensive, accurate, and fast results to help manage the pandemic Helen Albert
35 [GO] 2021―Feb―12 Most Healthcare Workers Have Low SARS-CoV-2 Infection Risks at Work
36 [GO] 2021―Feb―12 Evidence Suggests SARS-CoV-2 Spike Protein Can Enter the Brain
37 [GO] 2021―Feb―12 At-Home SARS-CoV-2 Test From DxTerity to be Sold Through Amazon
38 [GO] 2021―Feb―12 Still in the Grips of the Pandemic Chris Anderson
39 [GO] 2021―Feb―12 Mental Health is Diagnostic Pandemic Ready
40 [GO] 2020―Dec―04 NIH Launches COVID-19 Clinical Trial of Immune Modulators
41 [GO] 2020―Dec―04 Baylor Genetics Launches At-Home COVID-19 Collection Kit
42 [GO] 2020―Dec―04 NIH Grants $234M to Expand Testing for COVID-19 in Minority Communities
43 [GO] 2020―Dec―04 Testing Conundrum: The rapid roll-out of COVID-19 testing has lawmakers and stakeholders wrestling anew with how to regulate laboratory developed tests Alex Philippidis
44 [GO] 2020―Dec―04 Drug Targets and Possible Treatments for Combating Multiple Coronaviruses Identified
45 [GO] 2020―Dec―04 SARS-CoV-2 Antibodies Decrease Three Months After Infection
46 [GO] 2020―Oct―02 Next-Generation Sequencing Proves Crucial in Fight Against COVID-19
47 [GO] 2020―Oct―02 RNA for Medical Analysis: From Mendelian disorders to COVID-19, academic and industrial scientists use these nucleic acids to help diagnose diseases Mike May
48 [GO] 2020―Oct―02 Northwell Health Releases Data on COVID-19 Antibody Testing of its Frontline Staff
49 [GO] 2020―Oct―02 Leveraging Technology and Collaboration to Tackle the COVID-19 Pandemic: Illumina employees meet the challenge of developing an NGS-based COVID-19 diagnostic in record time while also supporting worldwide research efforts into all aspects of SARS-CoV-2
50 [GO] 2020―Oct―02 AI Tool Finds Hundreds of Potential COVID-19 Drugs
51 [GO] 2020―Oct―02 New COVID-19 Inflammatory Response Pathway Revealed
52 [GO] 2020―Oct―02 NIH Launches Remdesivir Plus Interferon Beta-1a Trial for COVID-19 Treatment
53 [GO] 2020―Oct―02 Getting COVID-19 Vaccine and Therapeutics Right Chris Anderson
54 [GO] 2020―Oct―02 T Cells that Recognize SARS-CoV-2 May Be Leftover from Past Coronavirus Infections
55 [GO] 2020―Jul―31 Convalescent Plasma Shows Promise for Treating Serious COVID-19
56 [GO] 2020―Jul―31 RNA-Seq Shows Thrombotic Complications in COVID-19 Patients Linked to Platelet Hyperreactivity
57 [GO] 2020―Jul―31 Building a COVID-19 Pop-Up Testing Lab: Postdocs working in the lab of Jennifer Doudna at UC Berkeley bring the testing lab online in just three weeks. Jennifer Hamilton
58 [GO] 2020―Jul―31 Researchers Identify Common COVID-19 Susceptibility Genes
59 [GO] 2020―Jul―31 Moving Beyond PCR: Next-generation sequencing enters the COVID-19 testing arena Julianna LeMieux
60 [GO] 2020―Jul―31 Moderna's COVID-19 Vaccine Speeds to Phase III Trial After More Positive Data Alex Philippidis
61 [GO] 2020―Jul―31 Asymptomatic People Infected with SARS-CoV-2 May Have Weaker Immune Response to Virus
62 [GO] 2020―Jul―31 Newer, Dominant SARS-CoV-2 Variant Infects at Higher Rate than Earlier Dominant Virus
63 [GO] 2020―Jun―07 Staying Relevant: Molecular diagnostics providers seek ways to maintain services in a world consumed by COVID-19 Faye Nourollahi
64 [GO] 2020―Jun―07 Rutgers Launches Prospective Study of Health Care Workers Exposed to COVID-19
65 [GO] 2020―Jun―07 The First 44 FDA EUA Tests for COVID-19
66 [GO] 2020―Jun―07 CRISPR Comes of Age-As a Diagnostic: Hailed for its gene editing power, Sherlock Bioscience's COVID-19 diagnostic is the first CRISPR technology to gain FDA approval Julianna LeMieux
67 [GO] 2020―Jun―07 The Ripple Effect of COVID-19 on Precision Medicine Chris Anderson
68 [GO] 2020―Jun―07 NIH to Study Impact of COVID-19 on Rare Disease Community
69 [GO] 2020―Jun―07 COVID-19 Precipitates Sharp Decline in Cancer Testing, Diagnoses
70 [GO] 2020―Jun―07 5 COVID-19 Test Developers to Watch: The coronavirus pandemic compels diagnostics companies to bring new assays, technologies to market Alex Philippidis
71 [GO] 2020―Jun―07 NIH Launches $1.5B Rapid COVID-19 Testing Technology Challenge
72 [GO] 2020―Jun―07 European Biotechs Plan Single-Dose Adenovirus COVID-19 Vaccine
73 [GO] 2020―Jun―07 Fully Human Antibody Discovered that Neutralizes Coronavirus
74 [GO] 2020―Jun―07 Iceni Diagnostics Eyes Fall Release of At-Home Coronavirus Test
75 [GO] 2020―Jun―07 Portable Coronavirus Test Developed Using Microfluidics and a Cell Phone
76 [GO] 2020―Jun―07 NIAID Study Launched to Determine SARS-CoV-2 Infection Incidence in US Children
77 [GO] 2020―Jun―07 Pfizer, BioNTechSE SARS-CoV-2 Vaccine Trial Launches in US

77 Results       Page 1


Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.012 sec